Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) SHH

64.76

+2.2(+3.52%)

Updated at August 19 02:16PM

Currency In CNY

Chengdu Easton Biopharmaceuticals Co., Ltd.

Address

No.8, Xiyuan Avenue

Chengdu, 611731

China

Phone

86 28 6758 5121

Sector

Healthcare

Industry

Biotechnology

Employees

1400

First IPO Date

September 02, 2020

Key Executives

NameTitlePayYear Born
Mr. Daming ZhangDeputy GM & Director01974
Mr. Mingxu YuanGM & Director01973
Ms. Shuyun LiBoard Secretary01985
Mr. Zheng Pin GuanDeputy GM & Core Technician01974
Mr. Avinash Ramkisan ManeChief Scientist of Formulation Research Department & Core Technician01978
Mr. Hua ZhuTechnical Director & Core Technician01981
Ms. Xiao Qin BoChief Financial Officer & Accounting Supervisor01982
Mr. Zenggui ChenDeputy GM & Director01972
Mr. Chen HongDeputy GM & Core Technician01964
Mr. Xingyao SongDeputy General Manager01977

Description

Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.